利拉鲁肽
厌食
后脑区
孤核
内分泌学
内科学
兴奋剂
医学
胰高血糖素样肽-1
下丘脑
受体
后脑
神经科学
中枢神经系统
生物
食物摄入量
糖尿病
2型糖尿病
作者
Samantha M. Fortin,Rachele K. Lipsky,Rinzin Lhamo,Jack Chen,Eun Kyung Kim,Tito Borner,Heath D. Schmidt,Matthew R. Hayes
标识
DOI:10.1126/scitranslmed.aay8071
摘要
The glucagon-like peptide-1 receptor (GLP-1R) agonist liraglutide is approved for the treatment of obesity; however, there is still much to be learned regarding the neuronal sites of action that underlie its suppressive effects on food intake and body weight. Peripherally administered liraglutide in rats acts in part through central GLP-1Rs in both the hypothalamus and the hindbrain. Here, we extend findings supporting a role for hindbrain GLP-1Rs in mediating the anorectic effects of liraglutide in male rats. To dissociate the contribution of GLP-1Rs in the area postrema (AP) and the nucleus tractus solitarius (NTS), we examined the effects of liraglutide in both NTS AAV-shRNA-driven
科研通智能强力驱动
Strongly Powered by AbleSci AI